000 | 01214 a2200337 4500 | ||
---|---|---|---|
005 | 20250513184754.0 | ||
264 | 0 | _c19990709 | |
008 | 199907s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/S0140-6736(99)01443-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWilson, A M | |
245 | 0 | 0 |
_aImportance of drug-device interaction in determining systemic effects of inhaled corticosteroids. _h[electronic resource] |
260 |
_bLancet (London, England) _cJun 1999 |
||
300 |
_a2128 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Letter; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 | _aFluticasone |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNebulizers and Vaporizers |
700 | 1 | _aDempsey, O J | |
700 | 1 | _aCoutie, W J | |
700 | 1 | _aSims, E J | |
700 | 1 | _aLipworth, B J | |
773 | 0 |
_tLancet (London, England) _gvol. 353 _gno. 9170 _gp. 2128 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(99)01443-9 _zAvailable from publisher's website |
999 |
_c10341059 _d10341059 |